Biofrontera (BFRI) Financials: Revenue & Earnings
BFRI$0.83-0.01 -1.00%
$12.35M
Market Cap
-1.39
P/E
4.16
Forward P/E
—
Score
Biofrontera (BFRI) Financials: Revenue & Earnings
BFRI price $0.83 -0.01 -1.00%
- Ticker
- BFRI
- Price
- $0.83
- Change
- -0.01 -1.00%
- Market cap ?
- $12.35M
- P/E ?
- -1.39
- Forward P/E ?
- 4.16
- Dividend yield ?
- 0.00%
- Beta ?
- 0.88
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 26181000 | 18849000 | 24100000 | 28674000 | 34071000 | 37303000 | 41705000 |
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn…
Fair value
BFRI fair value $6.17. Price $0.83. Price is 87% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.58M. Growth 10.66%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.11% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 14.85M. Net debt -231.00K. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.22 | — | 8.25M |
| 2026-08-13 | -0.05 | -0.10 | 12.00M | 9.50M |
| 2026-05-14 | -0.41 | -0.18 | 10.08M | 10.25M |
| 2026-03-19 | 0.50 | 0.20 | 17.10M | 16.15M |
| 2025-11-12 | -0.59 | -0.60 | 6.99M | 7.00M |
| 2025-08-13 | -0.57 | -0.45 | 9.03M | 8.30M |
| 2025-05-15 | -0.47 | -0.21 | 8.59M | 10.55M |
| 2025-03-21 | -0.19 | 0.02 | 12.56M | 14.55M |
| 2024-11-13 | -0.98 | -0.83 | 9.01M | 10.00M |
| 2024-08-14 | -0.05 | -0.77 | 7.84M | 8.21M |
| 2024-05-15 | -2.88 | -1.17 | 7.91M | 10.86M |
| 2024-03-18 | 1.65 | -1.19 | 10.59M | 11.52M |
| 2023-11-10 | -4.64 | -3.78 | 8.90M | 8.43M |
| 2023-08-11 | -7.23 | -5.14 | 5.85M | 6.20M |
| 2023-05-12 | -4.40 | -3.90 | 8.73M | 9.15M |
| 2023-03-08 | -2.09 | -2.20 | 10.14M | 10.35M |
| 2022-11-14 | -2.20 | -0.32 | 4.32M | 4.30M |
| 2022-08-12 | -8.80 | -6.20 | 4.46M | 4.55M |
| 2022-05-13 | -1.60 | -3.00 | 9.75M | 9.83M |
| 2022-04-08 | -8.40 | -3.60 | 9.17M | 9.24M |
| 2021-11-30 | -10.20 | -11.60 | 4.33M | 4.86M |
| 2021-11-01 | -9.20 | — | 5.86M | — |
| 2021-03-31 | -0.01 | — | 4.74M | — |
| 2020-09-30 | -0.01 | — | 3.25M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-28 | Luebbert Hermann | Buy | 62.50K | — | — |
| 2026-07-28 | Luebbert Hermann | Sell | 62.50K | — | — |
| 2026-07-28 | Leffler Eugene Frederick | Buy | 31.25K | — | — |
| 2026-07-28 | Leffler Eugene Frederick | Sell | 31.25K | — | — |
| 2026-03-05 | Luebbert Hermann | Buy | 137.50K | — | — |
| 2026-03-05 | Luebbert Hermann | Sell | 137.50K | — | — |
| 2026-03-05 | Leffler Eugene Frederick | Buy | 87.50K | — | — |
| 2026-03-05 | Leffler Eugene Frederick | Sell | 87.50K | — | — |
| 2026-03-04 | Weber Kevin Daniel | Buy | 20.00K | $0.90 | 18.00K |
| 2026-03-04 | Luebbert Hermann | Buy | 125.00K | $0.90 | 112.50K |
| 2026-03-04 | Luebbert Hermann | Buy | 125.00K | — | — |
| 2026-03-04 | Leffler Eugene Frederick | Buy | 62.50K | — | — |
| 2026-03-04 | Leffler Eugene Frederick | Buy | 62.50K | $0.90 | 56.25K |
| 2026-03-04 | Lanckriet Heikki | Buy | 20.00K | $0.90 | 18.00K |
| 2026-03-04 | Hoffman Beth J. | Buy | 20.00K | $0.90 | 18.00K |
| 2026-03-04 | Jones George Patrick | Buy | 50.00K | $0.90 | 45.00K |
| 2026-03-04 | Jones George Patrick | Buy | 50.00K | — | — |
| 2026-03-04 | BORER JOHN J III | Buy | 20.00K | $0.90 | 18.00K |
| 2025-09-16 | Link Christian Alexander Ansgar | Other | 0 | — | — |
| 2025-09-16 | VV Beteiligungen Aktiengesellschaft | Other | 0 | — | — |
| 2025-09-16 | VV Beteiligungen Aktiengesellschaft | Other | 0 | — | — |
| 2025-09-16 | VV Beteiligungen Aktiengesellschaft | Other | 4.83M | $0.62 | 3.02M |
| 2025-09-16 | DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | Other | 0 | — | — |
| 2025-09-16 | DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | Other | 0 | — | — |
| 2025-09-16 | DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | Other | 4.83M | $0.62 | 3.02M |
| 2025-09-16 | Plaggemars Hansjoerg | Other | 0 | — | — |
| 2025-09-16 | Zours Wilhelm Konrad Thomas | Other | 0 | — | — |
| 2025-09-16 | Zours Wilhelm Konrad Thomas | Other | 0 | — | — |
| 2025-09-16 | Zours Wilhelm Konrad Thomas | Other | 4.83M | $0.62 | 3.02M |
| 2025-09-16 | DEUTSCHE BALATON AKTIENGESELLSCHAFT | Other | 0 | — | — |
| 2025-09-16 | DEUTSCHE BALATON AKTIENGESELLSCHAFT | Other | 0 | — | — |
| 2025-09-16 | DEUTSCHE BALATON AKTIENGESELLSCHAFT | Other | 4.83M | $0.62 | 3.02M |
| 2025-09-16 | de la Huerta Martinez Maria del Pilar | Other | 0 | — | — |
| 2025-09-16 | de la Huerta Martinez Maria del Pilar | Other | 4.83M | $0.00 | 2.90K |
| 2025-09-16 | Biofrontera AG | Buy | 3.02K | $0.00 | 2 |
| 2025-09-15 | Jones George Patrick | Buy | 100.00K | $1.00 | 100.00K |
| 2025-09-10 | Luebbert Hermann | Buy | 137.50K | — | — |
| 2025-09-10 | Luebbert Hermann | Sell | 137.50K | — | — |
| 2025-09-10 | Leffler Eugene Frederick | Buy | 87.50K | — | — |
| 2025-09-10 | Leffler Eugene Frederick | Sell | 87.50K | — | — |
| 2025-08-25 | Jones George Patrick | Other | 0 | — | — |
| 2025-07-22 | Weber Kevin Daniel | Buy | 20.00K | $1.00 | 20.00K |
| 2025-07-22 | Luebbert Hermann | Buy | 125.00K | $1.00 | 125.00K |
| 2025-07-22 | Luebbert Hermann | Buy | 125.00K | — | — |
| 2025-07-22 | Leffler Eugene Frederick | Buy | 62.50K | — | — |
| 2025-07-22 | Leffler Eugene Frederick | Buy | 62.50K | $1.00 | 62.50K |
| 2025-07-22 | Lanckriet Heikki | Buy | 20.00K | $1.00 | 20.00K |
| 2025-07-22 | Hoffman Beth J. | Buy | 20.00K | $1.00 | 20.00K |
| 2025-07-22 | BORER JOHN J III | Buy | 20.00K | $1.00 | 20.00K |
| 2025-06-30 | Biofrontera AG | Other | 0 | — | — |
| 2024-07-12 | Weber Kevin Daniel | Buy | 20.00K | $1.38 | 27.60K |
| 2024-07-12 | Lanckriet Heikki | Buy | 20.00K | $1.38 | 27.60K |
| 2024-07-12 | Leffler Eugene Frederick | Buy | 175.00K | $1.38 | 241.50K |
| 2024-07-12 | Leffler Eugene Frederick | Buy | 175.00K | — | — |
| 2024-07-12 | Hoffman Beth J. | Buy | 20.00K | $1.38 | 27.60K |
| 2024-07-12 | Luebbert Hermann | Buy | 275.00K | $1.38 | 379.50K |
| 2024-07-12 | Luebbert Hermann | Buy | 275.00K | — | — |
| 2024-07-12 | BORER JOHN J III | Buy | 20.00K | $1.38 | 27.60K |
| 2024-05-18 | Luebbert Hermann | Buy | 4.77K | — | — |
| 2024-05-18 | Luebbert Hermann | Sell | 4.77K | — | — |
| 2023-07-03 | Lanckriet Heikki | Other | 0 | — | — |
| 2023-05-18 | Monaco Erica L. | Buy | 76.34K | — | — |
| 2023-05-18 | Monaco Erica L. | Sell | 76.34K | — | — |
| 2023-05-18 | Luebbert Hermann | Buy | 95.42K | — | — |
| 2023-05-18 | Luebbert Hermann | Sell | 95.42K | — | — |
| 2023-01-10 | Leffler Eugene Frederick | Buy | 100.00K | — | — |
| 2022-11-14 | Gates Erica F. | Other | 0 | — | — |
| 2022-10-24 | Leffler Eugene Frederick | Other | — | — | — |
| 2022-10-24 | Leffler Eugene Frederick | Other | 0 | — | — |
| 2022-05-18 | Wedge Loretta M. | Buy | 22.00K | $2.61 | 57.42K |
| 2022-05-18 | Weber Kevin Daniel | Buy | 22.00K | $2.61 | 57.42K |
| 2022-05-18 | BORER JOHN J III | Buy | 22.00K | $2.61 | 57.42K |
| 2022-05-18 | Hoffman Beth J. | Buy | 22.00K | $2.61 | 57.42K |
| 2022-05-18 | Gates Erica F. | Buy | 19.08K | — | — |
| 2022-05-18 | Monaco Erica L. | Buy | 152.67K | — | — |
| 2022-05-18 | Hoffman Beth J. | Buy | 22.00K | — | — |
| 2022-05-18 | Luebbert Hermann | Buy | 190.84K | — | — |
| 2022-05-18 | BORER JOHN J III | Buy | 22.00K | — | — |
| 2022-05-18 | Wedge Loretta M. | Buy | 22.00K | — | — |
| 2022-05-18 | Weber Kevin Daniel | Buy | 22.00K | — | — |
| 2022-03-02 | Weber Kevin Daniel | Other | 0 | — | — |
| 2021-12-09 | Monaco Erica L. | Buy | 56.69K | $4.77 | 270.41K |
| 2021-12-09 | Gates Erica F. | Buy | 20.41K | $4.77 | 97.35K |
| 2021-12-09 | Luebbert Hermann | Buy | 113.38K | $4.77 | 540.82K |
| 2021-12-09 | Luebbert Hermann | Buy | 113.38K | — | — |
| 2021-12-09 | Monaco Erica L. | Buy | 56.69K | — | — |
| 2021-12-09 | Monaco Erica L. | Buy | 56.69K | $4.41 | 250.00K |
| 2021-12-09 | Gates Erica F. | Buy | 20.41K | $4.41 | 90.00K |
| 2021-11-02 | Wedge Loretta M. | Other | 0 | — | — |
| 2021-11-02 | BORER JOHN J III | Other | 0 | — | — |
| 2021-11-02 | Hoffman Beth J. | Other | 0 | — | — |
| 2021-10-28 | Biofrontera AG | Sell | 0 | — | — |
| 2021-10-28 | Biofrontera AG | Other | 0 | — | — |
| 2021-10-28 | Luebbert Hermann | Other | 0 | — | — |
| 2021-10-28 | Gates Erica F. | Other | 0 | — | — |
| 2021-10-28 | Monaco Erica L. | Other | 0 | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 19, holders +7 vs prior quarter. Ownership 21.37%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 1.28M | 111.65K | +9.59% | 1.21M |
| AIGH CAPITAL MANAGEMENT LLC | 739.91K | -175.30K | -19.15% | 699.59K |
| RENAISSANCE TECHNOLOGIES LLC | 157.50K | 157.50K | New | 148.92K |
| CITADEL ADVISORS LLC | 104.94K | 104.94K | New | 99.22K |
| JANE STREET GROUP, LLC | 93.00K | 93.00K | New | 87.93K |
| GEODE CAPITAL MANAGEMENT, LLC | 76.69K | -32.61K | -29.84% | 72.51K |
| VANGUARD CAPITAL MANAGEMENT LLC | 71.38K | 19.13K | +36.60% | 67.53K |
| VANGUARD FIDUCIARY TRUST CO | 61.70K | 0 | 0.00% | 58.37K |
| XTX TOPCO LTD | 51.89K | 29.40K | +130.71% | 49.07K |
| HRT FINANCIAL LP | 43.35K | 43.35K | New | 40.00K |
| NORTHERN TRUST CORP | 31.54K | 31.54K | New | 29.82K |
| UBS GROUP AG | 18.52K | 16.98K | +1102.47% | 17.52K |
| JONES FINANCIAL COMPANIES LLLP | 10.00K | 10.00K | New | 9.71K |
| SANCTUARY ADVISORS, LLC | 10.20K | 0 | 0.00% | 9.64K |
| GSA CAPITAL PARTNERS LLP | 10.02K | 10.02K | New | 9.00K |
| BLACKROCK, INC. | 4.62K | 0 | 0.00% | 4.37K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 332 | 332 | New | 314 |
| SBI SECURITIES CO., LTD. | 305 | 0 | 0.00% | 288 |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 1 | 1 | New | 1 |
| CITIGROUP INC | 0 | -11.84K | -100.00% | 0 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0 | -38.57K | -100.00% | 0 |
Earnings and financials
Biofrontera Inc. (BFRI) trades at $0.83, with a market cap of $12.35M and a trailing P/E of -1.39. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 26181000 | 18849000 | 24100000 | 28674000 | 34071000 | 37303000 | 41705000 |
Insights · Dividends · Forecast · Financials · Learn